Modeling stroke in mice: Permanent coagulation of the distal middle cerebral artery

Journal of Visualized Experiments

Volumn , Issue 89, 2014, Pages

  Llovera, Gemma ^a,b   Roth, Stefan ^a,b   Plesnila, Nikolaus ^a,b   Veltkamp, Roland ^c,d   Liesz, Arthur ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Germany 3 Munich Cluster for Systems Neurology   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Animal model; Brain ischemia; Electrocoagulation; Issue 89; Medicine; Middle cerebral artery; Stroke

Indexed keywords

ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; MALE; MOUSE; PATHOLOGY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; STROKE;

EID: 84904689427     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51729     Document Type: Article

References (28)

1. Donnan, G. A. et al. Stroke. Lancet. 371, 1612-1623, doi:10.1016/S0140-6736(08)60694-7 (2008).
2. Di Carlo, A. et al. Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology. 54, S28-33 (2000).
3. Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329, doi:10.1056/NEJMoa0804656 (2008).
4. Jauch, E. C. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44, 870-947, doi:10.1161/STR.0b013e318284056a (2013).
5. Longa, E. Z. et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20, 84-91 (1989).
6. Engel, O. et al. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J. Vis. Exp. 47, e2423, doi:10.3791/2423 (2011).
7. Zhang, Z. et al. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17, 123-135, doi:10.1097/00004647-199702000-00001 (1997).
8. Tamura, A. et al. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1, 53-60 doi:10.1038/jcbfm.1981.6 (1981).
9. Chen, S. T. et al. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 17, 738-743 (1986).
10. Tureyen, K. et al. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J. Neurosci. Methods. 139, 203-207, doi:10.1016/j.jneumeth.2004.04.029 (2004).
11. Carmichael, S. T. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2, 396-409, doi:10.1602/neurorx.2.3.396 (2005).
12. Howells, D. W. et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 30, 1412-1431, doi:10.1038/jcbfm.2010.66 (2010).
13. Schallert, T. et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 39, 777-787 (2000).
14. Swanson, R. A. et al. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293 (1990).
15. Kitano, H. et al. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J. Cereb. Blood Flow Metab. 27, 1108-1128, doi:10.1038/sj.jcbfm.9600410 (2007).
16. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Stroke. 31, 2912-2919 (2000).
17. Sowell, E. R. et al. Mapping cortical change across the human life span. Nat. Neurosci. 6, 309-315, doi:10.1038/nn1008 (2003).
18. Brott, T. et al. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 20, 871-875 (1989).
19. Hacke, W. et al. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurol. 53, 309-315 (1996).
20. Majid, A. et al. Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke. 31, 2707-2714 (2000).
21. Liesz, A. et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J. Neurosci. 33(44), 17350-17362, 10.1523/JNEUROSCI.4901-12.2013 (2013).
22. Liesz, A. et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 134, 704-720, doi:10.1093/brain/awr008 (2011).
23. Jones, B. J., & Roberts, D. J. A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 259, 211 (1968).
24. Bouet, V. et al. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 4, 1560-1564, doi:10.1038/nprot.2009.125 (2009).
25. Zhang, L. et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 117, 207-214 (2002).
26. Orset, C. et al. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke. 38, 2771-2778, doi:10.1161/STROKEAHA.107.487520 (2007).
27. Farr, T. D., & Whishaw, I. Q. Quantitative and qualitative impairments in skilled reaching in the mouse (Mus musculus) after a focal motor cortex stroke. Stroke. 33, 1869-1875 (2002).
28. Kassem-Moussa, H., & Graffagnino, C. Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Arch. Neurol. 59, 1870-1873 (2002).